US 6759408
Combination regimens using progesterone receptor modulators
expired A61KA61K31/535A61K31/56
Quick answer
US patent 6759408 (Combination regimens using progesterone receptor modulators) held by Ligand Pharmaceuticals Incorporated expires Mon Jul 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Jul 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/535, A61K31/56